Success rate of peripartum myomectomy during cesarean delivery: a hospital-based study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20263020Keywords:
Cesarean myomectomy, Peripartum myomectomy, Postpartum hemorrhage, Uterine fibroidAbstract
Background: Although cesarean myomectomy was traditionally avoided because of hemorrhage risk, recent evidence suggests that it may be feasible in carefully selected women with appropriate surgical expertise and hemostatic support. Therefore, this study aimed to determine the success rate and short-term maternal outcomes of peripartum myomectomy performed during cesarean delivery.
Methods: This hospital-based observational study included 150 consecutive women with sonographic and/or intraoperative uterine fibroids undergoing cesarean delivery with planned peripartum myomectomy under spinal anesthesia at Salauddin Specialized Hospital, Dhaka, Bangladesh, between 2023 and 2025. The primary outcome was successful myomectomy without hysterectomy or abandonment. Secondary outcomes included postpartum hemorrhage, hemoglobin drop, transfusion, uterine atony, infection, hospital stay and in-hospital mortality.
Results: Mean maternal age was 31.2±5.4 years and mean gestational age was 38.1±1.7 weeks. Previous cesarean section was present in 52.0% of cases, while 58.7% were emergency procedures. Post-delivery myomectomy was performed in 96.7%. Mean operative time was 78.5±19.6 minutes and median blood loss was 850 mL (IQR 650–1100). Single fibroids occurred in 61.3% of patients, with a median size of 6.5 cm, mainly subserosal or intramural. Procedural success was achieved in 92.0%; hysterectomy and abandonment each occurred in 2.7%. Postpartum hemorrhage occurred in 12.0%, transfusion in 14.7%, fever in 10.7% and wound infection in 6.0%. Median hospital stay was 4 days, with no maternal deaths.
Conclusions: Cesarean myomectomy achieved a 92.0% success rate, with low hysterectomy rates and no maternal mortality. With careful patient selection, experienced surgeons and adequate hemorrhage-control measures, the procedure may be a feasible option for avoiding subsequent surgery.
References
Stewart EA, Cookson CL, Gandolfo RA, Schulze‐Rath R. Epidemiology of uterine fibroids: a systematic review. An Int J Obstet Gynaecol. 2017;124(10):1501-12.
Li H, Hu Z, Fan Y, Hao Y. The influence of uterine fibroids on adverse outcomes in pregnant women: a meta-analysis. BMC Pregn Child. 2024;24(1):345.
Boerma T, Ronsmans C, Melesse DY, Barros AJ, Barros FC, Juan L, et al. Global epidemiology of use of and disparities in caesarean sections. Lancet. 2018;392(15):1341-8.
Rana MS, Mazumder S, Khan MT, Khan MM, Rahman MM. Trends and determinants of caesarean section in South Asian countries: Bangladesh, Nepal and Pakistan. Plos One. 2024;19(12):311082.
Haider MR, Rahman MM, Moinuddin M, Rahman AE, Ahmed S, Khan MM. Ever-increasing Caesarean section and its economic burden in Bangladesh. PloS One. 2018;13(12):208623.
Goyal M, Dawood AS, Elbohoty SB, Abbas AM, Singh P, Melana N, et al. Cesarean myomectomy in the last ten years; A true shift from contraindication to indication: A systematic review and meta-analysis. European J Obstet Gynecol Reprod Biol. 2021;256:145-57.
Huang Y, Ming X, Li Z. Feasibility and safety of performing cesarean myomectomy: a systematic review and meta-analysis. J Maternal-Fetal Neon Med. 2022;35(13):2619-27.
Pergialiotis V, Sinanidis I, Louloudis IE, Vichos T, Perrea DN, Doumouchtsis SK. Perioperative complications of cesarean delivery myomectomy: a meta-analysis. Obstet Gynecol. 2017;130(6):1295-303.
El-Refaie W, Hassan M, Abdelhafez MS. Myomectomy during cesarean section: A retrospective cohort study. Journal of Gynecology Obstetrics and Human Reproduction. 2020;49(10):101900.
Zhao R, Wang X, Zou L, Zhang W. Outcomes of myomectomy at the time of cesarean section among pregnant women with uterine fibroids: a retrospective cohort study. BioMed Res Int. 2019;13(1):7576934.
Jarvi S, Aviram A, Jolliffe C, Wortsman S, Liu G, Berndl A, et al. Myomectomy at the time of cesarean delivery is not a predictor of transfusion among pregnant individuals with fibroids: a retrospective cohort study. American J Obstet Gynecol MFM. 2024;1;6(11):46.
Sparić R, Andrić L, Guler O, Malvasi A, Babović I, Hatirnaz S, et al. Cesarean myomectomy: reflections on clinical and surgical controversies between a new trans-decidual technique vs. traditional method. Medicina. 2024;8;60(4):609.
Na H, Lee KN, Kim Y, Kim BY, Park M, Song SY, et al. Outcomes of cesarean myomectomy in Singleton compared with twin pregnancies: a 10-year retrospective cohort study. BMC Surg. 2025;25(1):185.
Cochrane Central Editorial Service, Dey T, Cole MG, Brown D, Hill RA, Chaplin M, Huffstetler HE, Curtis F. Caesarean myomectomy in pregnant women with uterine fibroids. Cochrane Database of Systematic Reviews. 1996;1;2025(1):857.
Brennan LC, Werger M, Ivanisevic S, Han S, Tannenbaum E, Hobson SR, et al. Cesarean myomectomy for large uterine fibroids: Surgical outcomes from a single‐center case series. Int J Gynecol Obstetrics. 2026;172(2):1198-201.
Lee YE, Park S, Lee KY, Song JE. Risk factors based on myoma characteristics for predicting postoperative complications following cesarean myomectomy. PLoS One. 2023;18(3):280953.
Ramya T, Sabnis SS, Chitra TV, Panicker S. Cesarean myomectomy: an experience from a tertiary care teaching hospital. J Obstetrics Gynecol India. 2019;69(5):426-30.
Dedes I, Schäffer L, Zimmermann R, Burkhardt T, Haslinger C. Outcome and risk factors of cesarean delivery with and without cesarean myomectomy in women with uterine myomatas. Arch Gynecol Obstetrics. 2017;295(1):27-32.
Capozzi VA, Valentina C, Giulio S, Alessandra C, Giulia G, Giulia A, et al. Sentinel node mapping in endometrial cancer: Tips and tricks to improve bilateral detection rate. The sentitricks study, a monocentric experience. Taiwanese J Obstetrics Gynecology. 2021;60(1):31-5.
Senturk MB, Polat M, Doğan O, Pulatoğlu Ç, Yardımcı OD, Karakuş R, et al. Outcome of cesarean myomectomy: is it a safe procedure. Geburtshilfe Frauenheilkunde. 2017;77(11):1200-6.